Today: 22 May 2026
Nvidia stock steadies in premarket as earnings loom and AI spend faces scrutiny

Nvidia stock steadies in premarket as earnings loom and AI spend faces scrutiny

NEW YORK, Feb 24, 2026, 05:46 ET — Premarket

  • Nvidia is set to deliver its quarterly numbers after the bell on Wednesday. Investors are zeroed in on guidance and just how fast AI-driven demand is picking up.
  • Options are pointing to a sizable post-earnings swing—clear evidence the stock continues to steer broader sentiment.
  • Traders are eyeing pressure from homegrown chips, supply bottlenecks, and possible signals on China sales.

Nvidia shares barely budged in premarket trading Tuesday. The previous session finished higher for the chipmaker, with Wall Street now looking to its quarterly results—these could prove pivotal for the AI-driven rally.

Nvidia’s report is closely watched now—seen as a stand-in for gauging if Big Tech’s heavy data center investments are still delivering profit growth, and if those gains can outpace increasingly tough year-ago comparisons.

Options markets are signaling nerves, with traders pricing in a roughly 6% swing for the stock in either direction by week’s end. That kind of setup highlights just how keenly investors are positioned ahead of Wednesday’s numbers.

Monday’s session hit hard, with stocks falling as anxiety spiked over the pace of AI-driven upheaval across industries. “You’ve seen the market react to headlines, it’s ‘sell first, assess later,’” said Tom Hainlin, national investment strategist at U.S. Bank Wealth Management. Reuters

Nvidia changed hands at $191.55, putting it 0.9% above its prior finish.

Nvidia plans to report earnings around 4:20 p.m. ET on Feb. 25, with a conference call lined up for 5 p.m. ET. The company said written remarks from CFO Colette Kress will be published shortly after the results drop.

Investors are looking for clear evidence that earnings growth can keep up with the heavy spending pace. “This earnings in particular is important because people are so concerned about AI spending — whether we’re in a bubble,” said Ivana Delevska, chief investment officer at Spear Invest. Wall Street’s numbers: revenue likely surged over 68% to about $66.16 billion, while the first-quarter outlook sits at roughly $72.46 billion, per LSEG data reported by Reuters. Reuters

Talk of what’s ahead is intensifying. Hyperscalers—the big cloud players—are stepping up efforts on their own custom chips, just as Nvidia works to hold its ground in inference, the real-time answering process after model training. Seaport Research Partners’ Jay Goldberg flagged that capacity limits at TSMC’s advanced fabs could put a lid on gains.

Aletheia Capital bumped Nvidia up to “buy” from “hold” on Monday, slapping a $250 price target on the stock. The analysts said concerns around inventory build and rack deployment speed should ease starting in the fiscal fourth quarter. Investing.com South Africa

The bar is set high here. If there’s even a whiff that supply headaches, rivals, or export restrictions are reining in guidance, the reaction could be sharper than what you’d see with a less prominent stock.

Stock Market Today

  • NYSE's Martin Questions Nasdaq Rules Attracting SpaceX IPO
    May 22, 2026, 9:22 AM EDT. Lynn Martin, President of the New York Stock Exchange (NYSE), criticized some of the Nasdaq's listing rules used to attract SpaceX's public offering as "questionable." Speaking on Bloomberg Surveillance, Martin emphasized that market integrity should not be compromised for competitive gains between stock exchanges. She noted 2023 has been a strong year for initial public offerings (IPOs) across sectors and affirmed the NYSE's commitment to bringing more companies public. Martin's remarks highlight ongoing debates over regulatory standards and competitive practices in the IPO market.

Latest articles

Akari Therapeutics Stock Is Soaring Again — The KRAS Cancer Data Behind the Move

Akari Therapeutics Stock Is Soaring Again — The KRAS Cancer Data Behind the Move

22 May 2026
Akari Therapeutics shares more than doubled in premarket trading Friday after its lead cancer drug showed positive preclinical results in KRAS-mutated pancreatic cancer models and the company announced a $5.5 million private placement. The stock was quoted at $10.15, up from Thursday’s $5.14 close. Akari plans to start Phase 1 human trials of AKTX-101 by mid-2027. The company reported $2.8 million in cash at March 31.
BMO Lands Buy Rating Ahead of Earnings But Targets Raise Questions

BMO Lands Buy Rating Ahead of Earnings But Targets Raise Questions

22 May 2026
Canaccord Genuity reaffirmed a Buy rating on Bank of Montreal ahead of its May 27 earnings report. BMO shares closed May 21 at C$220.06, near a 52-week high and up 23.5% year-to-date. The bank recently agreed to sell C$14.5 billion in loan and lease assets to Stonepeak, expecting a CET1 ratio boost but a C$900 million after-tax charge. Analyst consensus remains mixed, with most holding or selling.
Atmos Energy’s run in Texas faces new Wall Street target cut

Atmos Energy’s run in Texas faces new Wall Street target cut

22 May 2026
Morgan Stanley lowered its Atmos Energy price target to $183 from $195, maintaining an Equalweight rating. The move follows Atmos’ recent increase in its 2026 earnings outlook and annual dividend. Atmos shares closed at $177.46 on Thursday. Texas remains central to Atmos’ growth and regulatory strategy, with 65% of its rate base in the state.
American Express stock tumbles 7% as “AI scare trade” hits payments; what to watch before the open
Previous Story

American Express stock tumbles 7% as “AI scare trade” hits payments; what to watch before the open

IBM stock steadies before the bell after Anthropic’s COBOL AI claim sparks worst day since 2000
Next Story

IBM stock steadies before the bell after Anthropic’s COBOL AI claim sparks worst day since 2000

Go toTop